Oxford Performance Materials (OPM), an advanced materials science and 3D printing solutions company for the orthopaedic industry, announced a significant investment from Scalpel Ventures, a venture capital firm specialising in healthcare innovation.
Scalpel Ventures, a venture capital firm specialising in healthcare innovation, was co-founded by Dr Selene Parekh, a renowned orthopaedic surgeon.
“Scalpel’s investment focus is on disruptive technologies and novel solutions, and from the outset it was clear to me that OPM’s OsteoFab technology represents a significant advancement in the field of orthopedic implants,” said Dr. Parekh. “Working with the OPM team, I performed the world’s first isolated PEKK total talus replacement surgery this spring, and a growing number of my colleagues are selecting OPM’s 3D printed, metal-free OsteoFab-Rx technology for their complex custom orthopedic procedures.”
With the support of Scalpel Ventures, OPM plans to expand the reach of OsteoFab technology and further increase the availability of these advanced 3D-printed implants. The investment marks an important step in the development of personalised orthopaedic medicine.
Scott DeFelice, CEO of Oxford Performance Materials, commented on the investment: “We are thrilled to partner with Scalpel Ventures to accelerate the growth of our OsteoFab platform. This investment will enable us to scale our operations and meet the increasing demand for personalized, metal-free orthopedic solutions.” DeFelice continued, “Scalpel Ventures shares our commitment to innovation and improving patient outcomes, and we look forward to working together to expand the impact of this unique technology.”
Subscribe to our Newsletter
3DPresso is a weekly newsletter that links to the most exciting global stories from the 3D printing and additive manufacturing industry.
